To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to the announcement that the Government has secured access to 90 million doses of promising coronavirus vaccine candidates, published on 20 July 2020 on gov.uk, what steps the Government is taking to help ensure that that access does not affect the availability of global vaccine stocks available for vulnerable groups in lower income countries.
The UK is working closely with international partners to ensure that when a vaccine is available, it will be accessible to everyone who needs it as soon as possible.
The UK has committed alongside other countries to support equitable and affordable access to COVID-19 vaccines and treatments for example, committing up to £250 million of UK aid to the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of coronavirus vaccines. The UK has already committed £48 million to the COVID-19 Global Vaccine Access Facility (COVAX) Advanced Market Commitment (AMC) which supports low and middle-income countries to access a successful vaccine.
The UK is also working closely with CEPI, GAVI (Vaccine Alliance) and the WHO to shape the emerging proposal for the self-financing arm of COVAX, which can support both domestic access and equitable access to LMICs.
We continue to work with our international partners to ensure that where countries have bilateral deals – including whether we be in the fortunate position where we have excess doses, these could be contributed to the COVAX facility.